“Determination of the most informative prognostic parameters for assessing the status of the epidermal growth factor receptor Her2/neu in the primary tumor in breast cancer patients using the targeted radiopharmaceutical «99mTc-ADAPT6»” (2021) Voprosy onkologii, 67(3), pp. 368–373. doi:10.37469/0507-3758-2021-67-3-368-373.